 Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis and monitoring. Clin Chem 2000; 46: 205068.  Manual de Patologia General - Página 329de Sisinio de Castro del Pozo, José Luis Pérez Arellano - 2007 - 769 páginasVista previa restringida - Acerca de este libro
 | Christopher P. Price, Robert H. Christenson - 2003 - 316 páginas
...Directions for a New Program, Field MJ, Lohr KN, eds. Washington, DC: National Academy Press, 1990:38. 2. Dufour DR. Lott JA, Nolte FS, Gretch DR, Koff RS,...in screening, diagnosis, and monitoring. Clin Chem 2000;46:2050-68. 3. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines... | |
 | Xavier Fuentes Arderiu - 2003 - 764 páginas
...characteristics of laboratory tests. Clin Chem 2000:46:2027-49. DUFOUR DR, LOTT JA, NOLTE FS, GRETCH D, KOFF RS, SEEFF LB. Diagnosis and monitoring of hepatic...in screening, diagnosis, and monitoring. Clin Chem 2000:46:2050-68. The Hepatitis Information Network. Hepatitis B. <http://www.hepnet. com/hepb.html>... | |
 | Walter G. Guder - 2005 - 1016 páginas
...Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520 Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. AASLD and National Academy of Clinical Biochemistry Practice Guidelines. Diagnosis and monitoring of... | |
 | Debra G.B. Leonard - 2007 - 600 páginas
...International Consensus Conference on Hepatitic C. Consensus statement. / Hepatol. 1999;30:956-961. 58. 39. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS,...tests in screening, diagnosis, and monitoring. Clin 59. Chem. 2000;46:2050-2068. 40. Centers for Disease Control and Prevention. Guidelines for labora-... | |
 | Geoffrey Lloyd, Elspeth Guthrie - 2007 - 903 páginas
...depressive disorders. Alcohol & Alcoholism, 36, 249—55. Dufour, DR, Lott, JA, Nolle, FS, et al. (2000). Diagnosis and monitoring of hepatic injury. II. Recommendations...laboratory tests in screening, diagnosis, and monitoring. Clinical Chemistry, 46, 2050-68. Edmonstone, WM (1995). How do we manage the first seizure in adults?... | |
 | Marc A. Reymond - 2007 - 788 páginas
...Leberzellkarzinom liegt zwischen 40-80%. Bis zu 10% aller Leberzellkarzinome sind AFP negativ. Literatur Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoringof hepatic injury. II Recommendations for use of laboratory tests in screening, diagnosis,... | |
 | Alfonso Balcells - 2007 - 472 páginas
...Sleisenger & Fordtran's Gastrointestinal and liver disease. Philadelphia: Saunders; 2002. p. 1227-39. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Laboratory Guidelines for screening, diagnosis and monitoring of hepatic injury. Clin Chem. 2000;46:2027-68.... | |
| |
